ArticleInternational journal of neonatal screening2017
Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.
Article in International journal of neonatal screening, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 31 citations in OpenAlex.
- Revolutionizing neonatal health: India's journey from assays to advanced genetics.Journal of applied genetics · 2026Review
- Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs.Applied health economics and health policy · 2026Review
- Emergency criteria and lifesaving intervention windows for high-risk critical congenital heart disease: a perspectives.Frontiers in cardiovascular medicine · 2026Article
- The Performance of Critical Congenital Heart Disease Screening in Rural Versus Urban Locations in the Northwest United States.Journal of pediatrics. Clinical practice · 2024Article
- An insight into Indonesia's progress for newborn screening program: What is currently going on.Heliyon · 2024Article
- Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning.Cost effectiveness and resource allocation : C/E · 2024Article
- Surgically Correctable Congenital Anomalies: Reducing Morbidity and Mortality in the First 8000 Days of Life.World journal of surgery · 2023Review
- Article
- Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.The Journal of pediatrics · 2020Article
- Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia.International journal of neonatal screening · 2020Review
- Acute therapy of newborns with critical congenital heart disease.Translational pediatrics · 2019Review
- Pulse Oximetry Screening for Critical Congenital Heart Defects: A Life-Saving Test for All Newborn Babies.International journal of neonatal screening · 2019Article
- Cost-effectiveness analysis of newborn pulse oximetry screening to detect critical congenital heart disease in Colombia.Cost effectiveness and resource allocation : C/E · 2019Article
- Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge.European journal of pediatrics · 2019Article
- What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?International journal of neonatal screening · 2018Article
- Cyanotic congenital heart disease - Not always blue to provide a clue: Time to replace cyanosis with arterial desaturation!Annals of pediatric cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
Abstract
Screening newborns for critical congenital heart disease (CCHD) using pulse oximetry is recommended to allow for the prompt diagnosis and prevention of life-threatening crises. The present review summarizes and critiques six previously published estimates of the costs or cost-effectiveness of CCHD screening from the United Kingdom, United States, and China. Several elements that affect CCHD screening costs were assessed in varying numbers of studies, including screening staff time, instrumentation, and consumables, as well as costs of diagnosis and treatment. A previous US study that used conservative assumptions suggested that CCHD screening is likely to be considered cost-effective from the healthcare sector perspective. Newly available estimates of avoided infant CCHD deaths in several US states that implemented mandatory CCHD screening policies during 2011-2013 suggest a substantially larger reduction in deaths than was projected in the previous US cost-effectiveness analysis. Taking into account these new estimates, we estimate that cost per life-year gained could be as low as USD 12,000. However, that estimate does not take into account future costs of health care and education for surviving children with CCHD nor the costs incurred by health departments to support and monitor CCHD screening policies and programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.